BRIEF-Lineage, Inc. Sees IPO Of 47 Mln Shares Of Common Stock- SEC Filing-February 2024-www.financetom.com

BRIEF-Lineage, Inc. Sees IPO Of 47 Mln Shares Of Common Stock- SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Lineage, Inc. Sees IPO Of 47 Mln Shares Of Common Stock- SEC Filing

Jul 16, 2024 4:39 AM

July 16 (Reuters) -

* LINEAGE, INC.: SEES IPO OF 47 MILLION SHARES OF COMMON

STOCK-

SEC FILING

* LINEAGE, INC.: EXPECT THE INITIAL PUBLIC OFFERING PRICE

OF OUR

COMMON STOCK TO BE BETWEEN $70.00 AND $82.00 PER SHARE

Source text for Eikon:

Further company coverage: [ ]

Previous page： Synovus Financial Launches Senior Notes Offering Next page： GDS' International Affiliate Raises $1 Billion for Expansion of Data Centers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Synovus Financial Launches Senior Notes Offering

Nov 3, 2024

09:41 AM EDT, 10/29/2024 (MT Newswires) -- Synovus Financial ( SNV ) said Tuesday it has launched an underwritten public offering of senior notes due 2030. Net proceeds will likely be used for general corporate purposes, which could include debt repayment, the company said. Price: 49.89, Change: -0.15, Percent Change: -0.30 ...

GDS' International Affiliate Raises $1 Billion for Expansion of Data Centers

Nov 3, 2024

09:41 AM EDT, 10/29/2024 (MT Newswires) -- GDS Holdings ( GDS ) said Tuesday that its international affiliate, DigitalLand, has secured $1 billion from institutional US investors, primarily led by Coatue Management and The Baupost Group, through a series B convertible preferred share issuance. The data center operator said the raised funds are expected to be able to fund the...

GlycoMimetics Agrees to Be Acquired by Crescent Biopharma; Shares Jump

Nov 3, 2024

09:44 AM EDT, 10/29/2024 (MT Newswires) -- GlycoMimetics' ( GLYC ) shares climbed by more than 125% early Tuesday after saying it has agreed to be acquired by Crescent Biopharma, a privately held biotechnology company advancing a pipeline of oncology therapeutics. Under the deal, a syndicate of investors has committed $200 million to buy GlycoMimetics ( GLYC ) common stock...

Royal Philips Wins $25 Million Contract From US Department of Defense for Infection Detection Technology

Nov 3, 2024

09:43 AM EDT, 10/29/2024 (MT Newswires) -- Royal Philips (PHG) said Tuesday it won a four-year, $25 million contract from US Department of Defense to accelerate the development of its Rapid Analysis of Threat Exposure, or RATE, used to detect early pre-symptomatic infection in humans. Over the next four years, the Joint Program Executive Office for Chemical, Biological, Radiological and...